Pentwater Capital Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-25,000
Closed -$2.07M 125
2014
Q1
$2.07M Buy
+25,000
New +$2.07M 0.06% 64